Researchers have successfully treated a patient with TTP, a rare blood disorder affecting 3,000 Americans annually, by suppressing the immune system. The treatment involves using immunosuppressive drugs, which target the underlying problem of the immune system attacking its own tissues.
Researchers found that a unique blood plasma volume expander can resuscitate rats after severe hemorrhage and apnea, with some surviving up to 7 days without blood transfusions. Hyperbaric oxygen appears to confer advantages in resuscitation and maintenance of circulation.
Researchers found that increased concentrations of asymmetrical dimethylarginine (ADMA) are a strong predictor of death and cardiovascular disease in haemodialysis patients. Middle-aged men with normal kidney function also showed a higher risk of acute coronary events with high ADMA levels.
Researchers have developed a new screening process to detect human parvovirus B19 in blood plasma, ensuring its safety for transfusions. The discovery has already led to improvements in plasma processing and the voluntary recall of contaminated lots.
A study found that folic acid supplements and fortified breakfast cereals are effective in lowering plasma tHcy, with significant decreases of 24% and 21% respectively. Increased consumption of folate-rich foods had a lesser effect on homocysteine levels.
A new Ohio University study found that 10% of college students have sold their blood plasma for payments, often using the funds for nonessential goods. The study revealed that paid student donors come from higher-income families and are more likely to engage in unhealthy lifestyle practices.